Caplin Point Laboratories (BOM:524742) ROE % Adjusted to Book Value : 4.86% (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Caplin Point Laboratories ROE % Adjusted to Book Value?

Caplin Point Laboratories's ROE % for the quarter that ended in Mar. 2024 was 21.00%. Caplin Point Laboratories's PB Ratio for the quarter that ended in Mar. 2024 was 4.32. Caplin Point Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 4.86%.

Caplin Point Laboratories ROE % Adjusted to Book Value Historical Data

The historical data trend for Caplin Point Laboratories's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Caplin Point Laboratories ROE % Adjusted to Book Value Chart

Caplin Point Laboratories Annual Data

Trend

Jun15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

11.10

8.26

6.47

9.28

5.04

Caplin Point Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															9.01	-	5.86	-	4.86

Competitive Comparison of Caplin Point Laboratories's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Caplin Point Laboratories's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Caplin Point Laboratories's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Caplin Point Laboratories's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Caplin Point Laboratories's ROE % Adjusted to Book Value falls into.

Caplin Point Laboratories ROE % Adjusted to Book Value Calculation

Caplin Point Laboratories's ROE % Adjusted to Book Value for the fiscal year that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.79%	/	4.32
	=	5.04%

Caplin Point Laboratories's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.00%	/	4.32
	=	4.86%

Caplin Point Laboratories ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Caplin Point Laboratories's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Caplin Point Laboratories (BOM:524742) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Caplin Point Laboratories Ltd (BOM:524742) » Definitions » ROE % Adjusted to Book Value

Traded in Other Exchanges

CAPLIPOINT:India

Address

Ashvich Tower, Developed Plots Industrial Estate, No. 3, 3rd Floor, Perungudi, Chennai, TN, IND, 600 096

Website

https://www.caplinpoint.net

Caplin Point Laboratories Ltd is the India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, liquid orals, dry powder, soft gels, penems injections, suppositories. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops. The business of the company is organized into the following product segments, Antibiotics, Nsaids, Ophthalmics, Pain Management, and Antiulcers. Its products have a presence in the Latin American and African markets.

Caplin Point Laboratories (BOM:524742) Headlines

No Headlines